Stakeholders
Topics
Institute for Value-Based Medicine
About AJMC
CME/CE
Subscribe
- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AHA Post Conference Perspectives: Emerging Therapies in Hypertrophic Cardiomyopathy (HCM)
home / post-conference-perspectives / aha-post-conference-perspectives-emerging-therapies-in-hypertrophic-cardiomyopathy-hcm-
An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.
